• 22/12/2022

    No More Pandemics: Training of national reference laboratory staff

    From 12-22 December 2022, in total eight staff members of the national reference laboratories from Kyrgyzstan, Tanzania and Vietnam were…

    Lees meer

  • 05/12/2022

    The story of Khasan and the shorter, improved TB regimen BPaL

    Khasan (1979): “I am a citizen of Uzbekistan, but I have been living in Russia with my family for several…

    Lees meer

  • 28/11/2022

    Congratulations to NTP Vietnam, for receiving the Ho Chi Minh Award on Science and Technology

    Last week, the National Tuberculosis Program (NTP) of Vietnam won the prestigious Ho Chi Minh Award on Science and Technology.

    Lees meer

  • 16/11/2022

    Register for the online symposium ‘Use of digital tools in support of treatment of people with tuberculosis’

    On Wednesday, November 30, the online symposium ‘Use of digital tools in support of treatment of people with tuberculosis’ will…

    Lees meer

  • 01/11/2022

    Publication: Preventive Treatment for Household Contacts of Drug-Susceptible Tuberculosis Patients

    Christiaan Mulder, Senior Epidemiologist at KNCV Tuberculosis Foundation, was part of the research “Preventive Treatment for Household Contacts of…

    Lees meer

  • 27/10/2022

    A story from Mulanje district, Southern region, Malawi

    Linda Kabotolo is a 27-year-old woman with two children. She comes from Mabuka in Matekenya village in Mulanje district. Kabotolo…

    Lees meer

  • 11/10/2022

    KNCV Tuberculosis Foundation launches the People-Centered Framework (PCF) Knowledge Hub

    KNCV Tuberculosis Foundation (KNCV) today announced the launch of the People-Centered Framework (PCF) Knowledge Hub, an online…

    Lees meer

  • 22/09/2022

    The Netherlands contributes € 180 million to end tuberculosis, HIV and malaria

    The Netherlands is contributing €180 million to the worldwide fight against tuberculosis (TB), HIV/AIDS and malaria. Minister Liesje Schreinemacher of…

    Lees meer

  • 05/08/2022

    KNCV is excited to join the USAID-funded, Johns Hopkins Medicine-led SMART4TB project

    With an investment of $200 million from USAID, Johns Hopkins Medicine launches the Supporting, Mobilizing and Accelerating Research…

    Lees meer

  • 08/04/2022

    Webinar: What’s next for Global Health in the wake of the pandemic?

    The Clingendael Institute organizes a series of online events regarding the complexities around the future of…

    Lees meer

  • 24/03/2022

    New LIFT-TB website highlights efforts to transform TB therapy amidst resurgence during COVID-19 pandemic

    The world continues to battle against two pandemics: COVID-19 and tuberculosis (TB). TB had long been the deadliest infectious disease—until…

    Lees meer

  • 24/03/2022

    ASCENT project: invest in innovative digital tools to end TB

    The Unitaid-funded ASCENT project has entered its final year and is well on its way in showing the benefits…

    Lees meer

  • 24/03/2022

    TREATS releases final report

    The TREATS (Tuberculosis Reduction through Expanded Antiretroviral Treatment and Screening for Active TB) project has just released its…

    Lees meer

  • 24/03/2022

    IMPAACT4TB raises awareness and access to TB Preventative Treatment

    About a quarter of the world’s population is infected with Mycobacterium Tuberculosis and thus at risk of developing tuberculosis (TB)…

    Lees meer

  • 24/03/2022

    KardiaMobile for ECG monitoring: Innovative approach to help DR-TB patients in Kazakhstan

    KNCV is constantly looking for innovative approaches for patient-centered care. Patients with drug resistant tuberculosis (DR-TB) who receive treatment with…

    Lees meer
Bezoek Nederlandse website

KNCV has been fighting TB since its establishment in 1903. Over the past 117 years, the organization has acquired indispensable knowledge and experience in the field of effective TB control, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework
Our patroness
Partner with us

Cambodia
Eswatini
Ethiopia
Ghana
Indonesia
Kazachstan
Kenya
Kyrgyzstan
Malawi
Namibia
Nigeria
Rwanda
South Africa
Tajikistan
Tanzania
Ukraine
Vietnam
Zambia

Tuberculosis is still one of the major causes of preventable death in the world and claims over 4000 lives a day, leading to over 1,5 million deaths a year.

Patient stories

The story of Abdurahim
The story of Fikeraddis
The story of Issayas
The story of Zarina
The story of Maxine
The story of Saanvi

KNCV’s Technical Assistance Strategy

New drugs & treatment regimens
Digital health solutions
Diagnosis & treatment of LTBI
TB Stigma reduction
Epidemiological measurement methodologies
New diagnostics and lab network design
People-Centred Framework for National Strategic Planning and HSS
Blended learning platform & methodologies

ASCENT
ASTTIE
Development of a comprehensive Digital Training Package
E-detect
GeneXpert MTB/RIF Test
IMPAACT4TB
PAVIA
People-Centered Framework for TB Programming
PODTEC
TB Alliance BPAL Project
The Global Fund to Fight AIDS, Tuberculosis and Malaria
TREATS

Our success stories

Challenge TB
Improved TB/HIV Prevention & Care – Building Models for the Future Project
TB REACH Ethiopia
TB REACH Nigeria
TB REACH Philippines
TB REACH Tanzania

KNCV Webinar: Impact of COVID-19: Hear the perspective of TB/MDR-TB patients and front line health care workers
KNCV Webinar: Contact Investigation for COVID-19: Lessons from TB Control Programs
KNCV Webinar ‘Infection prevention and control for COVID-19

Annual Report 2020
KNCV 2-pager ASCENT
KNCV 2-pager Childhood TB
KNCV 2-pager Digital Health
KNCV 2-pager General
KNCV 2pager Right Diagnosis, Right Treatment
KNCV 2-pager TB Photovoices
KNCV 2-pager TB Stigma

Address

KNCV Tuberculosefonds
Maanweg 174
2516 AB Den Haag
+31 70 416 7222

OPEN IN GOOGLE MAPS

Postal address

Postbus 146
2501 CC Den Haag

More information

Sorry

De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.